Functionality of beta-adrenergic receptors in patients with cirrhosis treated chronically with non-selective beta-blockers-Reference-Cited by-同舟云学术

Functionality of beta-adrenergic receptors in patients with cirrhosis treated chronically with non-selective beta-blockers

Published:2020-09 Issue:5 Volume:14 Page:858-868
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Almenara Susana,Lozano Beatriz,Gimenez Paula,Herrera Ivan,Miralles Cayetano,Bellot Pablo,Rodríguez María,Francés Rubén,Gonzalez-Navajas Jose M.,Pascual Sonia,Zapater Pedro^ORCID

Funder

Instituto de Salud Carlos III

Royal Academy of Medicine of the Valencian Community

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

https://link.springer.com/content/pdf/10.1007/s12072-020-10083-5.pdf

Reference30 articles.

1. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatol Baltim Md. 2006;43:S121–131.

2. Henriksen JH, Ring-Larsen H, Kanstrup IL, Christensen NJ. Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis. Gut. 1984;25:1034–43.

3. Floras JS, Legault L, Morali GA, Hara K, Blendis LM. Increased sympathetic outflow in cirrhosis and ascites: direct evidence from intraneural recordings. Ann Intern Med. 1991;114:373–80.

4. Ramond M, Comoy E, Lebrec D. Alterations in isoprenaline sensitivity in patients with cirrhosis: evidence of abnormality of the sympathetic nervous activity. Br J Clin Pharmacol. 1986;21:191–6.

5. Hernández FT, Zapater P, De-Madaria E, Palazón JM, Pascual S, Irurzun J, et al. Functional status of β-2-adrenoceptor in isolated membranes of mature erythrocytes from patients with cirrhosis and oesophageal varices. Vascul Pharmacol. 2006;44:464–8.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Selective Beta-Blockers in Patients with Cirrhosis: Current Evidence and Controversy;Liver Cirrhosis and Its Complications - Advances in Diagnosis and Management;2024-06-17

2. Immune changes over time and survival in patients with cirrhosis treated with non-selective beta-blockers: A prospective longitudinal study;Biomedicine & Pharmacotherapy;2023-07

3. Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?;Frontiers in Medicine;2023-01-09

4. Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes;Gut;2020-11-16